Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy
Authors:
Open Access
- 21 May 2020
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 11 (5) , 385
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD), and renal tubular cell dysfunction contributes to the pathogenesis of DN. Soluble epoxide hydrolase (sEH) is an enzyme that can hydrolyze epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids (EpFAs) into the less biologically active metabolites. Inhibition of sEH has multiple beneficial effects on renal function, however, the exact role of sEH in hyperglycemia-induced dysfunction of tubular cells is still not fully elucidated. In the present study, we showed that human proximal tubular epithelial (HK-2) cells revealed an upregulation of sEH expression accompanied by the impairment of autophagic flux, mitochondrial dysfunction, ubiquitinated protein accumulation and enhanced endoplasmic reticulum (ER) stress after high glucose (HG) treatment. Furthermore, dysfunctional mitochondria accumulated in the cytoplasm, which resulted in excessive reactive oxygen species (ROS) generation, Bax translocation, cytochrome c release, and apoptosis. However, t-AUCB, an inhibitor of sEH, partially reversed these negative outcomes. Moreover, we also observed increased sEH expression, impaired autophagy flux, mitochondrial dysfunction and enhanced ER stress in the renal proximal tubular cells of db/db diabetic mice. Notably, inhibition of sEH by treatment with t-AUCB attenuated renal injury and partially restored autophagic flux, improved mitochondrial function, and reduced ROS generation and ER stress in the kidneys of db/db mice. Taken together, these results suggest that inhibition of sEH by t-AUCB plays a protective role in hyperglycemia-induced proximal tubular injury and that the potential mechanism of t-AUCB-mediated protective autophagy is involved in modulating mitochondrial function and ER stress. Thus, we provide new evidence linking sEH to the autophagic response during proximal tubular injury in the pathogenesis of DN and suggest that inhibition of sEH can be considered a potential therapeutic strategy for the amelioration of DN.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 56 references indexed in Scilit:
- Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose TissueJournal of Biological Chemistry, 2013
- Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- The proximal tubule in the pathophysiology of the diabetic kidneyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 traffickingJournal of Neurochemistry, 2011
- Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 DiabetesExperimental Diabetes Research, 2011
- Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal DiseasePLOS ONE, 2010
- PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagyFEBS Letters, 2010
- Regulation Mechanisms and Signaling Pathways of AutophagyAnnual Review of Genetics, 2009
- Quality control of mitochondria: protection against neurodegeneration and ageingThe EMBO Journal, 2008
- Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized ratsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1992